Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Bioxytran, Inc

OTC: BIXT · Life Sciences · 2 alerts · CIK 1445815

Share price
$0.0230Close, Nov 13
Market cap
$2.64M
Shares outstanding
114.7MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Bioxytran, Inc filings on SEC EDGAR ↗

3:44 PM ET 8-K
Product Launch

Bioxytran Product Launch

Bioxytran, Inc. announced the commercial launch of its first two nutraceutical products, A-SUQAR for metabolic support and V-LO for immune support. The launch marks the clinical-stage biotech's expansion into the consumer wellness market, utilizing its carbohydrate-chemistry expertise. Both products are available immediately through the company's online storefront.

“For years, our team has worked on complex therapeutics for critical care and infectious diseases. Today we are bringing that same science directly to people’s doorsteps. Our entry into nutraceuticals is driven by a simple principle: apply rigorous scientific standards to everyday health. We have held these products to the same diligence we apply to our drug programs, so consumers get a high-quality, science-backed supplement they can trust.”

David Platt, Ph.D., Chief Executive Officer of Bioxytran

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.